Evidence map›Paper›PMID 38911160›Full record

ArticleRSC medicinal chemistry2024

The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics.

Neil Gerard Quigley, Maximilian Alexander Zierke, Beatrice Stefanie Ludwig, Frauke Richter, Nghia Trong Nguyen, Falco Reissig, Jakub Šimeček, Susanne Kossatz, Johannes Notni

Abstract read
In one paragraph

Article in RSC medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Neil Gerard QuigleyInstitute of Pathology, School of Medicine and Health, Technische Universität München Munich Germany.
Maximilian Alexander ZierkeInstitute of Pathology, School of Medicine and Health, Technische Universität München Munich Germany.
Beatrice Stefanie LudwigDepartment of Nuclear Medicine, University Hospital Klinikum Rechts der Isar and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine and Health, Technische Universität München Munich Germany.
Frauke RichterInstitute of Pathology, School of Medicine and Health, Technische Universität München Munich Germany.
Nghia Trong NguyenDepartment of Nuclear Medicine, University Hospital Klinikum Rechts der Isar and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine and Health, Technische Universität München Munich Germany.
Falco ReissigTRIMT GmbH Carl-Eschebach-Str. 7 D-01454 Radeberg Germany jn@trimt.de.
Jakub ŠimečekTRIMT GmbH Carl-Eschebach-Str. 7 D-01454 Radeberg Germany jn@trimt.de.
Susanne KossatzDepartment of Nuclear Medicine, University Hospital Klinikum Rechts der Isar and Central Institute for Translational Cancer Research, (TranslaTUM), School of Medicine and Health, Technische Universität München Munich Germany.
Johannes NotniInstitute of Pathology, School of Medicine and Health, Technische Universität München Munich Germany.ORCID https://orcid.org/0000-0002-3964-3391

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a recent paper in this journal (

Identifiers

PMID38911160
PMCPMC11187563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.